Gamida Cell approached but suitor remains undisclosed
This article was originally published in Clinica
Executive Summary
Stem cell therapy-developer Gamida Cell has been approached with a significant buyout offer from an unnamed big pharma company, two of the Israeli company's shareholders have confirmed.